18,587 articles
Matthæus Ratzeberger
Matthæus Ratzeberger (also spelled Ratzenberger), 1501 to 1559, was a German physician who treated Martin Luther and served as personal physician to Elector Johann Friedrich I of Saxony.
Matthew A. Wilson
Matthew A. Wilson is an MIT neuroscientist who records hundreds of neurons in freely behaving rats and showed in 1994 that the brain replays waking experience during sleep.
Matthew Anderson
Matthew Anderson is an American fungal geneticist and Associate Professor of Medical Genetics at the University of Wisconsin–Madison, known for studying genetic diversity in the human fungal pathogen Candida albicans.
Matthew B. Dalva
Matthew B. Dalva is a neuroscientist who directs the Tulane Brain Institute and studies how synapses develop and contribute to chronic pain, schizophrenia, and Alzheimer's disease.
Matthew B. Sullivan
Matthew B. Sullivan, also known as Matthew Sullivan, is an American virus ecologist and microbiologist at The Ohio State University who studies how ocean viruses shape microbial communities and global carbon cycling.
Matthew Berriman
Matthew Berriman, known as Matt Berriman, is a parasite genomics researcher who led the parasite genomics group at the Wellcome Sanger Institute and is now Professor of Parasitology at Glasgow.
Matthew Biggerstaff
Matthew Biggerstaff is an American infectious disease epidemiologist at the CDC who leads the Influenza Division's modeling team and helped build US epidemic forecasting systems.
Matthew Botvinick
Matthew Botvinick is a physician-scientist and AI researcher who held faculty posts at Penn and Princeton before serving as Senior Director of Research at Google DeepMind.
Matthew C. Gibson
Matthew C. Gibson is a developmental biologist and Investigator at the Stowers Institute for Medical Research in Kansas City, Missouri, known for his 2011 Cell paper on epithelial topology.
Matthew C. Kiernan
Matthew C. Kiernan, also known as Matthew Kiernan, is an Australian neurologist and CEO of Neuroscience Research Australia, known for ALS research and the Sheila Essey Award.
Matthew C. Whitby
Matthew C. Whitby is a Professor of Molecular Genetics at the University of Oxford who studies homologous recombination and genome stability, known for work on RecG helicase and Fml1.
Matthew D. Breyer
Matthew D. Breyer is an American nephrologist who was a Vanderbilt professor of medicine for 21 years, then led diabetic kidney disease drug discovery at Eli Lilly and Janssen.
Matthew D. Galsky
Matthew D. Galsky is an American medical oncologist at Mount Sinai specializing in bladder and other genitourinary cancers, leading phase 3 immunotherapy trials in urothelial carcinoma.
Matthew D. Hellmann
Matthew D. Hellmann is a medical oncologist and drug developer, formerly of Memorial Sloan Kettering, known as lead author of the CheckMate 227 lung cancer immunotherapy trial reports.
Matthew D. Hirschey
Matthew D. Hirschey is an American metabolism researcher and Associate Professor at the Duke Molecular Physiology Institute, known for his 2010 Nature paper on the sirtuin SIRT3.
Matthew D. McHugh
Matthew D. McHugh is an American nurse scientist at the University of Pennsylvania who directs CHOPR and was elected to the National Academy of Medicine in 2020.
Matthew D. Scharff
Matthew D. Scharff is an American immunologist and cell biologist at Albert Einstein College of Medicine, elected to the National Academy of Sciences in 1982, known for work on somatic mutation and antibody diversity.
Matthew D. Welch
Matthew D. Welch is an American cell biologist and microbiologist at UC Berkeley who studies actin polymerization, the Arp2/3 complex, and how pathogens exploit the cytoskeleton.
Matthew E. Ritchie
Matthew E. Ritchie is a computational biologist who leads the Genetics and Gene Regulation division at WEHI in Melbourne, known for the limma RNA-seq software and mixture-control benchmarks of single-cell and long-read analysis tools.
Matthew F. Krummel
Matthew F. Krummel, known as Max Krummel, is an American immunologist and UCSF professor of pathology who co-discovered CTLA-4 blockade, the basis of checkpoint cancer immunotherapy.
Matthew F. S. Rushworth
Matthew F. S. Rushworth is a cognitive neuroscientist at the University of Oxford who studies the neural mechanisms of decision making and was elected a Fellow of the Royal Society in 2019.
Matthew Freeman (cell biologist)
Matthew Freeman is a British cell biologist and geneticist, Professor of Pathology at Oxford, known for discovering rhomboid proteases and iRhoms, and elected a Fellow of the Royal Society in 2006.
Matthew G. Vander Heiden
Matthew G. Vander Heiden is an American physician-scientist at MIT who studies cancer metabolism, directs the Koch Institute, and was elected to the National Academy of Medicine in 2024.
Matthew H. Spitzer
Matthew H. Spitzer is an immunologist and associate professor at UCSF, known for a 2017 Cell paper showing cancer immunotherapy requires immune activation beyond the tumor.
Matthew Hotopf
Matthew Hotopf is a British psychiatric epidemiologist and consultant liaison psychiatrist at King's College London, known for Lancet studies on chronic fatigue syndrome and Iraq veterans.
Matthew Hurles
Matthew Hurles is a British human geneticist who became Director of the Wellcome Sanger Institute in 2023, known for the Deciphering Developmental Disorders study, which identified over 100 new rare genetic diseases.
Matthew I. Banks
Matthew I. Banks is a neuroscientist and Professor of Anesthesiology at the University of Wisconsin-Madison whose research studies how anesthesia and brain connectivity alter consciousness.
Matthew J. Dalby
Matthew J. Dalby is Professor of Cell Engineering at the University of Glasgow, known for showing that nanoscale surface disorder can drive stem cells to make bone without growth factors.
Matthew J. During
Matthew J. During was a New Zealand-born neuroscientist whose 1994 work established AAV gene delivery to the brain; he died in January 2025, aged 66.
Matthew J. Ellis
Matthew J. Ellis is a breast cancer oncologist and cancer genomics researcher who directed the Lester and Sue Smith Breast Center at Baylor and joined AstraZeneca in 2022.